Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations

被引：278
作者：
Abdullah, Mardiaty Iryani [1 ,5 ]
Junit, Sarni Mat [1 ]
Ng, Khoon Leong [2 ]
Jayapalan, Jaime Jacqueline [3 ]
Karikalan, Barani [4 ]
Hashim, Onn Haji [1 ,3 ]
机构：
[1] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur 50603, Malaysia
[3] Univ Malaya, Ctr Prote Res, Fac Med, Kuala Lumpur 50603, Malaysia
[4] Perdana Univ, Jalan MAEPS Perdana, Serdang 43400, Selangor, Malaysia
[5] Int Islamic Univ Malaysia, Kulliyyah Allied Hlth Sci, Dept Biomed Sci, Kuantan 25200, Pahang, Malaysia
来源：
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2019年 / 16卷 / 03期
关键词：
papillary thyroid cancer; molecular alteration; genetic signature; biomarker; diagnostics; FINE-NEEDLE-ASPIRATION; BRAF V600E MUTATION; ONCOGENE REARRANGEMENTS; EXPRESSION PROFILES; CLINICAL-FEATURES; TUMOR PROGRESSION; NUCLEAR FEATURES; GROWTH-FACTOR; UP-REGULATION; CARCINOMA;
D O I：
10.7150/ijms.29935
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations.
引用
收藏
页码：450 / 460
页数：11
相关论文
共 50 条
[21]   ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer [J].
Jin, Yuchen ;
Qiu, Xian ;
He, Ziyan ;
Wang, JunYao ;
Sa, Ri ;
Chen, Libo .
FRONTIERS IN GENETICS, 2022, 13
[22]   KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression [J].
Wen, Jialiang ;
Lin, Bangyi ;
Lin, Lizhi ;
Chen, Yizuo ;
Wang, Ouchen .
AGING-US, 2020, 12 (16) :16437-16456
[23]   The Role of Different Molecular Markers in Papillary Thyroid Cancer Patients with Acromegaly [J].
Keskin, Fatma Ela ;
Ozkaya, Hande Mefkure ;
Ferahman, Sina ;
Haliloglu, Ozlem ;
Karatas, Adem ;
Aksoy, Figen ;
Kadioglu, Pinar .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2019, 127 (07) :437-444
[24]   Changes in antioxidant status and DNA repair capacity are corroborated with molecular alterations in malignant thyroid tissue of patients with papillary thyroid cancer [J].
Eng, Zing Hong ;
Aziz, Azlina Abdul ;
Ng, Khoon Leong ;
Mat Junit, Sarni .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
[25]   A biomarker and molecular mechanism investigation for thyroid cancer [J].
Xie, Keju .
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 48 (03) :203-218
[26]   DIO3OS as a potential biomarker of papillary thyroid cancer [J].
Wang, Ye ;
Wang, Junfu ;
Wang, Congjun ;
Chen, Yeyang ;
Chen, Junqiang .
PATHOLOGY RESEARCH AND PRACTICE, 2022, 229
[27]   S100A12 is a promising biomarker in papillary thyroid cancer [J].
Wang, Xiaojie ;
Sun, Zhenxiang ;
Tian, Wei ;
Piao, Chenghao ;
Xie, Xiaochen ;
Zang, Jin ;
Peng, Shiqiao ;
Yu, Xiaohui ;
Wang, Yiwei .
SCIENTIFIC REPORTS, 2020, 10 (01)
[28]   Genetic and Epigenetic Association of FOXP3 with Papillary Thyroid Cancer Predisposition [J].
Achilla, Charoula ;
Chorti, Angeliki ;
Papavramidis, Theodosios ;
Angelis, Lefteris ;
Chatzikyriakidou, Anthoula .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
[29]   The Profile of Genetic Mutations in Papillary Thyroid Cancer Detected by Whole Exome Sequencing [J].
Fang, Yi ;
Ma, Xiao ;
Zeng, Jing ;
Jin, Yanwen ;
Hu, Yong ;
Wang, Jinjing ;
Liu, Ran ;
Cao, Cheng .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 50 (01) :169-178
[30]   Molecular pathways associated with mortality in papillary thyroid cancer [J].
Nilubol, Naris ;
Sukchotrat, Chotiya ;
Zhang, Lisa ;
He, Mei ;
Kebebew, Electron .
SURGERY, 2011, 150 (06) :1023-1031
12345